HEALTH RISKS
Abdominal obesity deserves medical attention.
Central adiposity is associated with increased risk of type 2 diabetes, high blood pressure and cardiovascular disease. NICE assessment guidance
The purpose of assessment is to find out what matters in your case and what can appropriately be addressed.
WHY LOOK BENEATH THE SURFACE?
Excess visceral fat is associated with insulin resistance, adverse blood-fat patterns and inflammatory processes linked to cardiovascular disease. These are medical concerns, not simply questions of body shape. AHA scientific statement
Abdominal obesity is a cardiovascular risk marker independent of BMI. American Heart Association
High blood pressure, abnormal cholesterol and elevated blood glucose can contribute to the risk of heart disease and stroke. NIDDK
We assess relevant risks and advise what needs treatment or further clinical evaluation.
Excess visceral fat is linked to insulin resistance, and central adiposity is associated with increased type 2 diabetes risk. Visceral adiposity review NICE
Your glucose results, history and other findings guide the next decision; appearance alone does not diagnose either condition.
Metabolic dysfunction-associated steatotic liver disease (MASLD) involves excess liver fat and is more common in people with obesity or type 2 diabetes. NIDDK liver health
Some people develop inflammation and scarring, but severe liver damage is not an inevitable consequence of fatty liver. Liver disease progression
The clinical picture determines whether liver assessment is needed.
Obesity increases the risk of obstructive sleep apnoea, a condition in which breathing repeatedly stops or becomes restricted during sleep. NIDDK breathing risks
Tell your doctor about loud snoring, witnessed breathing pauses or daytime sleepiness. The findings guide whether sleep assessment or specialist input is appropriate.
High blood pressure, high triglycerides and low HDL cholesterol usually cause no symptoms. Feeling well does not reliably exclude these risk factors. NHLBI
The task is to assess your individual risk and decide what needs attention now, not assume disease from appearance.
THE INDIAN / SOUTH ASIAN CONTEXT
People of South Asian background can develop cardiometabolic risk at a lower BMI. NICE therefore recommends considering ethnic background and central adiposity when assessing risk, rather than relying on BMI alone. NICE NG246
That is a reason to assess carefully, not to assume that every Indian patient has metabolic disease.
MEASURE. INTERPRET. DECIDE.
Some metabolic risks cause no obvious symptoms. Measurements and investigations help reveal what needs attention. NHLBI symptoms Assessment guidance
We interpret the findings alongside your medical and family history, current medicines and concerns.
| Marker | Threshold or qualifying treatment |
|---|---|
| Waist circumferenceSouth Asian adults | Men: ≥90 cm Women: ≥80 cmIndian Journal of Medical Research |
| Blood pressure | Systolic ≥130 OR diastolic ≥85 mmHgOr antihypertensive treatment for previously diagnosed hypertension.Consensus criteria |
| Fasting plasma glucose | ≥100 mg/dLOr drug treatment for elevated glucose.Consensus criteria |
| Triglycerides | ≥150 mg/dLOr specific drug treatment for elevated triglycerides.Consensus criteria |
| HDL cholesterol | Men: <40 mg/dL Women: <50 mg/dLOr specific drug treatment for reduced HDL cholesterol.Consensus criteria |
Under the harmonised criteria, any three of these five findings meet the criteria for metabolic syndrome. An elevated waist measurement is not compulsory. Joint consensus statement
Each finding deserves individual consideration. Your doctor assesses what needs attention and whether treatment or follow-up is appropriate.
These are syndrome criteria, not a stand-alone diagnosis of diabetes or hypertension. Your overall health and any existing treatment still need assessment. NHLBI diagnosis
BEYOND THE FIVE MARKERS
Your history guides any further assessment. This is not an automatic test package.
Excess visceral adiposity can contribute to inflammatory processes involved in vascular disease. That does not mean a visible belly measures inflammation or that everyone needs an inflammatory-marker panel. AHA scientific statement
BMI does not distinguish fat mass from lean mass, and similar body weights can conceal different amounts of visceral fat. Measurements need interpretation. Clinical Liver Disease
Tell your doctor about fatigue, disturbed sleep, difficulty concentrating or changes in everyday activity. These symptoms have many possible causes and do not, by themselves, establish poor metabolic health. Clinical assessment
Your current medicines, previous treatment response and relevant nutritional concerns belong in the assessment. Recommendations follow the clinical picture, not a universal supplement list.
Higher body fatness is associated with increased risk of several cancers, including colorectal, pancreatic, endometrial and postmenopausal breast cancer. National Cancer Institute
This is evidence about excess body fat and population-level risk, not a diagnosis from abdominal appearance. The programme is not a cancer-screening service; individual concerns and appropriate screening belong in your wider medical care.
Obesity is associated with osteoarthritis and can increase the mechanical load on joints. NIDDK joint health
Pain, mobility and physical capacity are worth discussing. They are not automatically explained by abdominal fat, and improvement is an individual objective rather than a guaranteed outcome.
PERSONAL CONCERNS. MEDICAL QUESTIONS.
These concerns deserve a respectful conversation, not embarrassment or a product recommendation without assessment.
Erectile dysfunction can be associated with obesity, diabetes, vascular disease or hormone problems; medicines and psychological factors can also contribute. NIDDK causes of ED
The American Urological Association identifies ED as a risk marker for underlying cardiovascular disease and other conditions that may warrant evaluation. It is not proof of heart disease in an individual. AUA guideline
Obesity is also associated with low testosterone in men. Diagnosis requires relevant symptoms and consistently low levels on appropriate blood tests, not a judgement based on body shape. Endocrine Society
Changes in libido, menstrual patterns, fertility or urinary symptoms also belong in the conversation. We consider what needs further assessment or specialist input, rather than assuming abdominal fat is the cause.
WHAT MEASUREMENTS CAN TELL US
Waist measurements and BMI can help assess risk, but they do not replace a clinical assessment. NICE uses waist-to-height ratio alongside BMI in adults with BMI below 35 kg/m² as a practical estimate of central adiposity. NICE measurement recommendations
We look at the relevance of each result, what remains uncertain and whether a finding changes the medical plan. More tests are not automatically better care.
See how the programme worksNEXT
